‌

US Patent 11649438 Methods and compositions for treating cancer

Patent 11649438 was granted and assigned to CRISPR Therapeutics on May, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

CRISPR Therapeutics

Current Assignee

CRISPR Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

116494380

Patent Inventor Names

Jonathan Alexander Terrett0

Demetrios Kalaitzidis0

Mary-Lee Dequéant0

Zinkal Samir Padalia0

Date of Patent

May 16, 2023

Patent Application Number

172387410

Date Filed

April 23, 2021

Patent Citations

‌

US Patent 10442849 Compositions and methods for TCR reprogramming using fusion proteins

‌

US Patent 10166255 Intracellular genomic transplant and methods of therapy

‌

US Patent 10584352 Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system

Patent Citations Received

‌

US Patent 12012458 Genetically modified natural killer cells for CD70-directed cancer immunotherapy

Patent Primary Examiner

‌

Maria Marvich

Provided herein, in some embodiments, are methods and compositions (e.g., cell compositions) for the treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11649438 Methods and compositions for treating cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API